Goa Pharma Proprietor Seeks Anticipatory Bail Over Alleged Spurious Antivenom Supply
In a significant development in Goa, Upendra Kumar Singh, the proprietor of Aarav Pharma, has been accused of supplying alleged spurious snake antivenom antiserum vials to the Goa directorate of health services. Following these serious allegations, Singh approached the court seeking anticipatory bail to avoid immediate arrest.
Court Extends Interim Protection Amid Ongoing Investigation
A Mapusa court has extended interim protection to Singh until the next date of hearing, which is scheduled for Friday, February 20. This decision provides temporary relief to Singh as the legal proceedings continue, allowing him to remain free while the case is under review.
Complaints Filed by Original Manufacturer and Health Directorate
The case escalated when the original manufacturer of the life-saving antivenom drugs, along with the directorate of health services, filed formal police complaints regarding the alleged spurious supply. These complaints highlighted concerns over the quality and safety of the antivenom vials, which are critical for treating snakebite emergencies.
Subsequently, an FIR was registered in the matter, marking the official start of a police investigation into the allegations. The involvement of multiple parties, including the health services and the drug manufacturer, underscores the seriousness of the accusations and the potential public health implications.
Authorities are now scrutinizing the supply chain and quality control measures to ensure such incidents do not recur, emphasizing the importance of stringent regulations in pharmaceutical distribution.
